Jerry L. Spivak, MD, discusses treating patients with polycythemia vera, which is a type of myeloproliferative neoplasm that can often derive from essential thrombocythemia, particularly among women.
Treating Asymptomatic Patients With Polycythemia... - MPN Voice
Treating Asymptomatic Patients With Polycythemia Vera
Written by
Manouche
To view profiles and participate in discussions please or .
Read more about...
1 Reply
•
This is a good link, thank you, as it also contains very interesting discussions with Ruben Mesa on early/pre-MF.
Not what you're looking for?
You may also like...
Bomedemstat in Patients With Polycythemia Vera
inhibitor, bomedemstat (IMG-7289), in patients with polycythemia vera. This study investigates the...
Abbas Weighs Options in Patient With JAK2-Mutated Polycythemia Vera
Jonathan Abbas, MD, discussed data on therapies for a patient with polycythemia vera who did not...
FDA Issues Complete Response Letter for Ropeginterferon Alfa-2b for Polycythemia Vera
for the treatment of patients with polycythemia vera »...
Thrombotic Events in Patients With Polycythemia Vera and Essential Thrombocythemia
thrombosis in PV and ET aside from elevations in hematologic parameters. For one, patients who...
Increased Besremi Dose to Be Studied for Polycythemia Vera Treatment
trial will involve approximately 100 patients with polycythemia vera. They will be randomly...
New Study: Predicted Survival in Polycythemia Vera Patients
diagnosed with Polycythemia Vera 
